Finally, we isolated GFP+S100a4+ CD4+ T cells from S100a4+/- and S100a4−/− host gliomas and co-cultured them for 4 days with in vitro activated, fluorescently-labeled B6 CD3+ splenocytes. This evidence concerns the gene S100A4 and central nervous system cancer.